Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 3
Date Title
15/05/2012 Request for Ireland to act as RMS in an MRP for medicinal products for human use
23/12/2011 Rasilez (aliskiren) - Important Safety Information from Novartis as approved by the Irish Medicines Board
24/10/2011 Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
04/10/2011 Revatio (sildenafil citrate) - Important Safety Information from Pfizer Healthcare Ireland as approved by the Irish Medicines Board
03/10/2011 Rimcazole Clinical Trial at Shandon Clinic – IMB Report
22/09/2011 Romiplostim (Nplate) - Important Safety information from AMGEN Ireland as approved by the Irish Medicines Board
21/06/2011 Report of consumption of veterinary antimicrobials in Ireland in 2009
20/06/2011 Regranex Gel (becaplermin 0.01%) - Important Safety Information from Janssen-Cilag Ltd as approved by the Irish Medicines Board
09/05/2011 Revlimid (lenalidomide) – risk of venous and arterial thromboembolic events
12/04/2011 Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
11/02/2011 Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
13/12/2010 RoActemra (tocilizumab) - Important Safety Information from Roche as approved by the Irish Medicines Board
08/11/2010 Rosiglitazone (Avandia/Avandamet) and Cardiovascular Risk
02/11/2010 Roaccutane (isotretinoin) - Important Safety Information from Roche as approved by the Irish Medicines Board
07/10/2010 Report of the Working Group on the Methods of Supply of Companion Animal Antiparasitic Medicines
28/09/2010 Rosiglitazone-containing products (Avandia, Avandamet, and Avaglim) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board
27/09/2010 RELISTOR (methylnaltrexone bromide) - Important Safety Information from Wyeth as approved by the Irish Medicines Board
23/09/2010 Rosiglitazone–containing Medicines (Avandia, Avandamet and Avaglim) – Important Safety Information issued by the Irish Medicines Board
07/09/2010 Rosiglitazone (Avandia/Avandamet) and Cardiovascular Risk
28/07/2010 Rosiglitazone–containing Medicines (Avandia/Avandamet) – Direct Healthcare Professional Communication issued by the Irish Medicines Board
Page 1 of 3



Date Printed: 19 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971